Vestura Shortage Update: What Patients Need to Know in 2026

If you've been searching for Vestura updates or wondering why your pharmacy no longer carries it, here's a clear, up-to-date picture of the situation. The short answer: Vestura as a brand name has been discontinued — but the medication it delivered is still available in 2026.

What Happened to Vestura?

Vestura (drospirenone 3 mg / ethinyl estradiol 0.02 mg) was manufactured by Teva Pharmaceuticals USA, Inc. as a branded generic of Yaz. Teva made a business decision to discontinue the Vestura brand — not because of safety concerns, but because of manufacturing and commercial factors that sometimes affect generic drug lines.

Before the full discontinuation, patients also reported inconsistent stocking at pharmacies — a sign that manufacturing capacity for Vestura was winding down. These supply disruptions were a frustrating early warning of the eventual discontinuation.

Is This a Safety Issue?

No. Vestura was not recalled or withdrawn for safety reasons. There is no FDA safety alert associated with Vestura. The discontinuation was a manufacturer business decision, similar to what happens with many generic drug lines when a company decides to focus on different products.

What Is Still Available in 2026?

The active ingredients in Vestura — drospirenone 3 mg and ethinyl estradiol 0.02 mg — remain widely available from multiple manufacturers. The following FDA-approved equivalents are currently on the market:

• Nikki — closest inactive ingredient profile to Vestura
• Loryna — widely stocked at major retail pharmacies
• Gianvi — common pharmacy substitute when switching from Vestura
• Yaz (brand) — original brand name; more expensive but widely available
• Drospirenone/ethinyl estradiol (unbranded generic) — available from multiple manufacturers at many pharmacies

How Does the Discontinuation Affect Patients?

For most patients, the practical impact is that your pharmacy will no longer be able to order Vestura specifically. If you present a prescription written for "Vestura," the pharmacist will likely substitute a generic equivalent — typically Gianvi, Loryna, or plain drospirenone/EE. In most cases, this substitution is automatic and legal.

For a smaller subset of patients, the switch to a different generic may cause side effects related to different inactive ingredients. If you experience new symptoms after switching, speak with your prescriber about trying a different generic formulation.

Will Vestura Ever Come Back?

It's unlikely that Vestura as a brand will return. Once a manufacturer discontinues a branded generic and clears out its supply chain, it rarely reverses that decision. However, because the underlying drug is still widely produced by other manufacturers, patients are not without options.

What Should Patients Do Right Now?

1. Talk to your prescriber about updating your prescription to specify a preferred generic (Nikki is a good first choice for most Vestura users).
2. Confirm your pharmacy's stock before your next refill — don't wait until you've run out.
3. Consider a 90-day supply once you find a generic that works for you, to minimize refill disruptions.
4. Use medfinder — medfinder.com calls pharmacies near you to check which ones have your preferred generic in stock and texts you the results.

More Resources

For a deep dive into which generics are most similar to Vestura, read Alternatives to Vestura If You Can't Fill Your Prescription.

And if cost is a concern with your new generic, see How to Save Money on Vestura in 2026.